Literature DB >> 16922657

Clinical pharmacology of bimatoprost.

Louis B Cantor1.   

Abstract

Bimatoprost (Lumigan), Allergan) is a highly efficacious ocular hypotensive agent that provides good diurnal control of intraocular pressure in glaucoma and ocular hypertensive patients. Bimatoprost is a synthetic molecule that is structurally and pharmacologically similar to prostamide F(2), and appears to mimic the activity of the prostamides. Consistent with prostamide-mimetic activity, bimatoprost has potent inherent pharmacological activity in prostamide-sensitive preparations and essentially remains intact in the living primate eye. This is sufficient to explain its potent and efficacious ocular hypotensive activity, and suggests that bimatoprost is a pharmacologically unique compound.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16922657     DOI: 10.1517/17425255.1.1.151

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  6 in total

1.  Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.

Authors:  Sudharshan Hariharan; Mukul Minocha; Gyan P Mishra; Dhananjay Pal; Rohit Krishna; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2009-12       Impact factor: 2.671

2.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

3.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

4.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29

5.  Hirsutism following the use of bimatoprost eyedrops for glaucoma.

Authors:  Subashini Kaliaperumal; Indu Govindaraj; Praveen Kumar Kopparapu; Shashi Ahuja
Journal:  J Pharmacol Pharmacother       Date:  2014-07

6.  Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study.

Authors:  Khulood Muhammad Sayed; Engy Mohammed Mostafa; Amr Mounir; Nesreen G Abd Elhaliem; Alahmady Hamad Alsmman
Journal:  Clin Ophthalmol       Date:  2019-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.